Unknown

Dataset Information

0

FDA recommended potent drugs against COVID-19: Insight through molecular docking.

ABSTRACT: Human Coronavirus (COVID-19) is a worldwide pandemic of 2019-20 that was emerged in China in December 2019. More than 37,000deaths with7, 84, 440confirmed cases has been reported from around 200 different countries has been reported till now and the number is increasing every second. The spread is said to be through human to human transmission via close contact or respiratory droplets produced when people cough or sneeze. No treatment for the illness has been approved yet. The urgent need is to find solution to this growing problem that has affected the whole mankind. World Health Organisation (WHO) as well as US Food and Drug Administration (FDA) are continuously working to find the solution. In the same line they have proposed many potent drugs that may have efficiency against the newly emerged viral infection. To support the efforts the present study is designed to carry out the in silico analysis viz. Docking studies of around 16drugs recently recommended by US FDA by observing the interaction of test molecules with SARS proteinase.

SUBMITTER: Gumber K 

PROVIDER: S-EPMC7832574 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

FDA recommended potent drugs against COVID-19: Insight through molecular docking.

Gumber Khushbu K   Pomila  

Materials today. Proceedings 20210113

Human Coronavirus (COVID-19) is a worldwide pandemic of 2019-20 that was emerged in China in December 2019. More than 37,000deaths with7, 84, 440confirmed cases has been reported from around 200 different countries has been reported till now and the number is increasing every second. The spread is said to be through human to human transmission via close contact or respiratory droplets produced when people cough or sneeze. No treatment for the illness has been approved yet. The urgent need is to  ...[more]

Similar Datasets

Unknown Repurposing drug molecule against SARS-Cov-2 (COVID-19) through molecular docking and dynamics: a quick approach to pick FDA-approved drugs.
| S-EPMC8487339 | biostudies-literature
Unknown Discovery of Novel Pyruvate Kinase Inhibitors Against <i>Leishmania major</i> Among FDA Approved Drugs Through System Biology and Molecular Docking Approach.
| S-EPMC8744444 | biostudies-literature
Unknown Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study.
| S-EPMC9007924 | biostudies-literature
Unknown In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs.
| S-EPMC8475441 | biostudies-literature
Unknown Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.
| S-EPMC4102417 | biostudies-literature
Unknown Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
| S-EPMC8604796 | biostudies-literature
Unknown Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.
| S-EPMC8293696 | biostudies-literature
Unknown Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
| S-EPMC10974395 | biostudies-literature
Unknown Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19.
| S-EPMC7682959 | biostudies-literature
Unknown Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.
| S-EPMC9202290 | biostudies-literature